Cambridge Investment Research Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $81K | Buy |
46,949
+1,072
| +2% | +$1.85K | ﹤0.01% | 3492 |
|
|
2025
Q1 | $153K | Buy |
45,877
+5,237
| +13% | +$17.5K | ﹤0.01% | 3272 |
|
|
2024
Q4 | $301K | Sell |
40,640
-1,229
| -3% | -$9.1K | ﹤0.01% | 2828 |
|
|
2024
Q3 | $393K | Buy |
41,869
+5,535
| +15% | +$52K | ﹤0.01% | 2610 |
|
|
2024
Q2 | $291K | Buy |
36,334
+9,074
| +33% | +$72.7K | ﹤0.01% | 2726 |
|
|
2024
Q1 | $404K | Buy |
+27,260
| New | +$404K | ﹤0.01% | 2460 |
|